Sildenafil citrate in the management of diabetic erectile dysfunction
Geoffrey Ian Hackett
Abstract
Geoffrey Ian Hackett
Abstract
The efficacy and safety of sildenafil citrate (Viagra) in the treatment of erectile dysfunction (ED) in diabetic men have been investigated in randomised, placebo-controlled trials. In all trials and across all subgroups of patients, sildenafil was associated with improvements in erectile function compared with placebo and side-effects of treatment (mainly headache, flushing and dyspepsia) were mostly transient and mild-to-moderate. Sildenafil is, therefore, concluded to be an effective and well-tolerated treatment for ED in men with diabetes.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The efficacy and safety of sildenafil citrate (Viagra) in the treatment of erectile dysfunction (ED) in diabetic men have been investigated in randomised, placebo-controlled trials. In all trials and across all subgroups of patients, sildenafil was associated with improvements in erectile function compared with placebo and side-effects of treatment (mainly headache, flushing and dyspepsia) were mostly transient and mild-to-moderate. Sildenafil is, therefore, concluded to be an effective and well-tolerated treatment for ED in men with diabetes.
Key concepts: Sildenafil, Erectile dysfunction, Medicine, Placebo, Diabetes mellitus, Erectile function, Urology, Clinical trial